Overweight and Obesity | OMICS International
ISSN: 2165-7904
Journal of Obesity & Weight Loss Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Overweight and Obesity

Selthofer-Relatić K1,2*

1Department for Cardiovascular Disease, University Hospital Centre Osijek, Croatia

2Department for Internal Medicine, School of Medicine Osijek, Croatia

Corresponding Author:
Kristina Selthofer Relatic
PhD, Assistant Professor
Department for Internal Medicine
Specialist for Internal Medicine – Clinical Hospital Centre Osijek, Croatia
E-mail: [email protected]

Received Date: July 10, 2012; Accepted Date: July 12, 2012; Published Date: July 14, 2012

Citation: Selthofer-Relatić K (2012) Overweight and Obesity. J Obes Wt Loss Ther S1:e001. doi:10.4172/2165-7904.S1-e001

Copyright: © 2012 Selthofer-Relatić K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Obesity & Weight Loss Therapy

Adipokines; Cardiomyopathy; Inflammatory; Obesity; Overweight; Hypertension
Obesity is a chronic disorder, defined by World Health Organisation as global health problem, that causes psyhosocial stress, morbidity and premature death [1,2]. Prevalence of obesity is growing progressively, in children, midle and old aged. It is a risk factor for conventional cardiovascular risk factors, but also it is an independent predictor for cardiovascular and metabolic diseases [3,4]. Most studies have focused on obese patients, and less on overweight patients, with body mass index in range 25-29.99 kg/m2. Today we know that overweight is early stage of obesity, with related patohistologic and pathophysiologic tissue and organs changes/damages.
Overweight/obesity is global increased disease associated with cardiovascular morbidity and mortality, related to insulin resistance and diabetes mellitus, hypertension, dyslipidemia, coronary artery disease, congesive heart failure, chronic kidney disease and social problems like anxiodepresive disorders [5,6]. It is characterized by increased adipose tissue mass that may function as endocrine organ, producing numbers of proinflammatory cytokines, adipokines and free fatty acids [7]. The main pathophysiologic changes of overweight/ obesity are inflammatory, insulin resistance, oxidative stress, hormonal factors and endothelial dysfunction.
Overweight/obesity are measured and defined according to body mass index calculation. Latest research has indicate that body fat distribution plays a more determinant role in defining disease risk than body mass, so persons with higher proportion of visceral fat are at higher risk for related diseases [8,9]. Waist circumference and waist-tohip ratio are index for body fat distribution.
Today it is very important to stress that overweight/obesity are diseases with complex disorders that involves apetite (dis)regulation and energy metabolisam, self control and physical (in)activity [1]. According to latest research, cardiovascular risk factors were also found in overweight children and adolescents, so screening for cardiovascular risk factors is very usefull at any age and degree of increased body mass index [10]. Metabolic and hormonal alterations occur early in overweight subjects while they are still clinically healthy. Increaseing evidence suggest that effective strategies of weight loss is needed, as a first step in overweight/obesity treatment. That includes combinated theraphy: diethary theraphy, behavioral interventions and apropriate physical activity. The worldwide obesity and related diseases have a lot of publicity in the media, but the level of public awareness about the adverse effects did not lead to an effective approach to problem solving and acceptance [11].
Acccording to all these facts, it can be concluded that world is dealing with newly recognized high-risk cardiometabolic factors, beginning with the development in overweight stadium, wich is a prestage of obesity and related diseases. Further investigations in this area are needed to clarify pathophysiologic processes in this early stages of overweight/obesity, to make further strategies in prevention and treatment.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 4546
  • [From(publication date):
    July-2012 - Sep 18, 2021]
  • Breakdown by view type
  • HTML page views : 638
  • PDF downloads : 3908